Metro-Minnesota CCOP is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.
Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Metro-Minnesota CCOP has participated in 30 clinical trials with 2 currently active.
Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Sponsors: National Cancer Institute (NCI), NSABP Foundation Inc, Alliance for Clinical Trials in Oncology.
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Metro-Minnesota CCOP has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Metro-Minnesota CCOP has 30 clinical trials on record, with 2 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Metro-Minnesota CCOP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.